about
GSK-3 promotes conditional association of CREB and its coactivators with MEIS1 to facilitate HOX-mediated transcription and oncogenesisTargeted Gene Correction in Osteopetrotic-Induced Pluripotent Stem Cells for the Generation of Functional OsteoclastsMLL becomes functional through intra-molecular interaction not by proteolytic processingPbx1 restrains myeloid maturation while preserving lymphoid potential in hematopoietic progenitors.Fusion between cancer cells and macrophages occurs in a murine model of spontaneous neu+ breast cancer without increasing its metastatic potential.Pbx1 regulates self-renewal of long-term hematopoietic stem cells by maintaining their quiescence.Anti-CD3ε mAb improves thymic architecture and prevents autoimmune manifestations in a mouse model of Omenn syndrome: therapeutic implications.A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation.Recovery of hematopoietic activity in bone marrow from human immunodeficiency virus type 1-infected patients during highly active antiretroviral therapy.Immune reconstitution in ADA-SCID after PBL gene therapy and discontinuation of enzyme replacement.Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning.IL-3 or IL-7 increases ex vivo gene transfer efficiency in ADA-SCID BM CD34+ cells while maintaining in vivo lymphoid potential.Expression of CXCR4, the receptor for stromal cell-derived factor-1 on fetal and adult human lympho-hematopoietic progenitors.Mobilized blood CD34+ cells transduced and selected with a clinically applicable protocol reconstitute lymphopoiesis in SCID-Hu mice.ACKR2 in hematopoietic precursors as a checkpoint of neutrophil release and anti-metastatic activity.Osteopetrosis rescue upon RANKL administration to Rankl(-/-) mice: a new therapy for human RANKL-dependent ARO.Gene therapy for adenosine deaminase deficiency
P50
Q24319759-6ACB19D5-A43A-46FE-9681-3A7ACD78BAB6Q30398603-D34457BF-239A-4074-B4AF-884ADAFC686EQ34989041-26438245-27FD-4305-9E35-EE438277C99BQ37012035-6B588274-90FB-4B04-904F-49C095FB2B72Q37641521-1821F360-D58E-4400-A049-012621CA83F6Q38910582-CFAB54A5-DE41-4D54-B234-0120D777765CQ39598202-CE645F80-50DD-4C4E-A0B9-A306A8E382ACQ42611632-01988FC3-3B6A-4F3F-9E56-8AB6D89FF0EAQ42636475-DA918778-1993-493B-85A6-CD1FFF419814Q43976641-A7459797-FAD9-4603-AFCD-E5EBDBA813C8Q44044895-4F878CA2-82AA-48E2-BF01-C1F098C0FCEFQ45162922-CBF4A499-1C25-4B6C-AA52-0580DC307335Q45859015-A079E141-26EA-4F7E-95EE-D243F9F648F2Q45873741-746A35FA-F242-4634-90E2-6F8C30382F33Q50243849-A5BF886A-F81E-44A5-8A92-18402EF73299Q55056509-8C97D8CC-AE9B-4B39-AF23-5482CA71AF1FQ61913687-BDDBD408-C588-4D03-BA4C-3B79F8463D41
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Francesca Ficara
@ast
Francesca Ficara
@en
Francesca Ficara
@es
Francesca Ficara
@nl
Francesca Ficara
@sl
type
label
Francesca Ficara
@ast
Francesca Ficara
@en
Francesca Ficara
@es
Francesca Ficara
@nl
Francesca Ficara
@sl
prefLabel
Francesca Ficara
@ast
Francesca Ficara
@en
Francesca Ficara
@es
Francesca Ficara
@nl
Francesca Ficara
@sl
P1053
M-4624-2016
P106
P1153
6603536309
P21
P31
P3829
P496
0000-0003-1873-1189